The Pharmacy and Poisons Board (PPB) has issued an alert over a suspicious batch of counterfeit breast cancer treatment drug, Herceptin 440mg (Trastuzumab 440mg), detected in the market. According to the board, the product batch is claimed to be manufactured in Germany by Roche Products Limited, bearing the Batch number C5830083, manufactured in December 2021…